跳到主要内容
广告
  • 半岛投注体育官网Neurology.org
  • 期刊
    • 半岛投注体育官网
    • 临床实践
    • 教育
    • 遗传学
    • 神经免疫学与神经炎症
  • 在线部分
    • 半岛投注体育官网神经病学视频杂志俱乐部
    • 多样性、公平和包容(DEI)
    • 护理服务的创新
    • 实践的嗡嗡声
    • 当前实践
    • 住院医师和研究员
    • 无国界
  • bdappios下载地址
    • 新型冠状病毒肺炎
    • 争议与争论
    • 健康差异
    • 信息图
    • bdapp
    • 零假设
    • bdapp1中国有限公司
    • 话题无所不包的
    • bdappcom
  • bd官方平台
  • 芝加哥商品交易所
  • 关于
    • 关于期刊
    • bdapp.
    • 编辑委员会
  • 作者
    • 提交新稿件
    • 提交修改稿
    • 作者中心

高级搜索

主菜单

  • 半岛投注体育官网Neurology.org
  • 期刊
    • 半岛投注体育官网
    • 临床实践
    • 教育
    • 遗传学
    • 神经免疫学与神经炎症
  • 在线部分
    • 半岛投注体育官网神经病学视频杂志俱乐部
    • 多样性、公平和包容(DEI)
    • 护理服务的创新
    • 实践的嗡嗡声
    • 当前实践
    • 住院医师和研究员
    • 无国界
  • bdappios下载地址
    • 新型冠状病毒肺炎
    • 争议与争论
    • 健康差异
    • 信息图
    • bdapp
    • 零假设
    • bdapp1中国有限公司
    • 话题无所不包的
    • bdappcom
  • bd官方平台
  • 芝加哥商品交易所
  • 关于
    • 关于期刊
    • bdapp.
    • 编辑委员会
  • 作者
    • 提交新稿件
    • 提交修改稿
    • 作者中心
  • 首页
  • 最新文章
  • 最新一期
  • 过去的问题
  • 半岛投注体育官网神经病学视频杂志俱乐部
  • 住院医师和研究员

用户菜单

  • 订阅
  • 我的提醒
  • 登录

搜索

  • 高级搜索
半岛投注体育官网
首页
最广泛阅读和高度引用的同行评议神经学杂志半岛投注体育官网
  • 订阅
  • 我的提醒
  • 登录
网站的标志
  • 首页
  • 最新文章
  • 最新一期
  • 过去的问题
  • 半岛投注体育官网神经病学视频杂志俱乐部
  • 住院医师和研究员

分享

2023年2月7日 ;100 (6) 半岛体育app苹果下载 开放获取

炎症性疾病、炎症生物标志物和阿尔茨海默病

观察分析与孟德尔随机化

查看ORCID配置文件剑黄,鲍恩苏,城镇Karhunen,查看ORCID配置文件Dipender吉尔,查看ORCID配置文件Verena Zuber,Ari Ahola-Olli,Saranya Palaniswamy,Juha Auvinen,卡尔赫齐格,Sirkka Keinanen-Kiukaanniemi,Marko Salmi,查看ORCID配置文件Sirpa Jalkanen,查看ORCID配置文件Terho Lehtimaki,查看ORCID配置文件Veikko Salomaa,查看ORCID配置文件Olli T. Raitakari,查看ORCID配置文件保罗·m·马修斯,查看ORCID配置文件保罗·艾略特,康斯坦丁诺斯·k·齐里迪斯,Marjo-riitta Jarvelin,查看ORCID配置文件Ioanna Tzoulaki,查看ORCID配置文件阿巴斯Dehghan
第一次出版2022年11月16日, DOI: https://doi.org/10.1212/WNL.0000000000201489
剑黄
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
  • 黄健的ORCID记录
鲍恩苏
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
城镇Karhunen
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
Dipender吉尔
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
  • Dipender Gill的ORCID记录
Verena Zuber
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
  • Verena Zuber的ORCID记录
Ari Ahola-Olli
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
Saranya Palaniswamy
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
Juha Auvinen
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
卡尔赫齐格
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
Sirkka Keinanen-Kiukaanniemi
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
Marko Salmi
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
Sirpa Jalkanen
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
  • Sirpa Jalkanen的ORCID记录
Terho Lehtimaki
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
  • Terho的ORCID记录Lehtimäki
Veikko Salomaa
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
  • Veikko Salomaa的ORCID记录
Olli T. Raitakari
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
  • Olli T. Raitakari的ORCID记录
保罗·m·马修斯
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
  • Paul M. Matthews的ORCID记录
保罗·艾略特
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
  • 保罗·埃利奥特的ORCID记录
康斯坦丁诺斯·k·齐里迪斯
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
Marjo-riitta Jarvelin
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
Ioanna Tzoulaki
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
  • Ioanna Tzoulaki的ORCID记录
阿巴斯Dehghan
来自英国伦敦帝国理工学院公共卫生学院流行病学和生物统计学系(j.h., b.s., v.k., d.g., v.z., s.p., p.e., k.k.t., m.r j, ad);新加坡临床科学研究所(SICS) (j.h),新加坡科学、技术和研究机构(A*STAR);生命历程健康研究中心(v.k., s.p., j.a., s.k.k。,M.-r.J.), Faculty of Medicine, Research Unit of Mathematical Sciences (V.K.), University of Oulu, Finland; The Stanley Center for Psychiatric Research (A.A.-O.), Broad Institute of MIT and Harvard, Cambridge, MA; Analytical and Translational Genetics Unit (A.A.-O.), Massachusetts General Hospital, Boston; Institute for Molecular Medicine Finland (A.A.-O.), University of Helsinki; Research Unit of Biomedicine (K.-H.H.), Medical Research Center (MRC), University of Oulu, University Hospital, Finland; Department of Gastroenterology and Metabolism (K.-H.H.), Poznan University of Medical Sciences, Poland; Unit of Primary Care (S.K.-K., M.-r.J.), Oulu University Hospital; Healthcare and Social Services of Selänne (S.K.-K., I.T.), Pyhäjärvi, Finland and City of Oulu; MediCity and Institute of Biomedicine (M.S., S.J.), University of Turku; Department of Clinical Chemistry (T.L.), Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University; Finnish Institute for Health and Welfare (V.S.), Helsinki; Research Centre of Applied and Preventive Cardiovascular Medicine (O.T.R.), University of Turku; Department of Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital; Centre for Population Health Research (O.T.R.), University of Turku and Turku University Hospital, Finland; Department of Brain Sciences (P.M.M.), Faculty of Medicine, Imperial College London; UK Dementia Research Institute at Imperial College London (P.M.M., P.E.); MRC Centre for Environment and Health (P.E., M.-r.J.), School of Public Health, Imperial College London, United Kingdom; Department of Hygiene and Epidemiology (K.K.T.), University of Ioannina Medical School, Greece; Biocenter Oulu (M.-r.J.), University of Oulu, Finland; and Department of Life Sciences (M.-r.J.), College of Health and Life Sciences, Brunel University London, United Kingdom.
  • 在谷歌Scholar网站上找到这位作者
  • 在PubMed上找到这位作者
  • 在这个网站上搜索这位作者
  • 阿巴斯·德汉的ORCID记录
完整的PDF
简式
引用
炎症性疾病、炎症生物标志物和阿尔茨海默病
观察分析与孟德尔随机化
剑黄,博文苏,城镇Karhunen,Dipender吉尔,VerenaZuber,阿里Ahola-Olli,SaranyaPalaniswamy,胡哈Auvinen,卡尔赫齐格,SirkkaKeinanen-Kiukaanniemi,MarkoSalmi,SirpaJalkanen,TerhoLehtimaki,VeikkoSalomaa,奥利T。Raitakari,保罗·M。马修斯,保罗艾略特,Konstantinos K。Tsilidis,Marjo-riittaJarvelin,IoannaTzoulaki,阿巴斯Dehghan
半岛投注体育官网 2023年2月, One hundred. (6) e568-e581; DOI:10.1212 / WNL.0000000000201489

引文管理器格式

  • 助理
  • 书挡
  • 值得
  • 尾注(标记)
  • EndNote 8 (xml)
  • 枸杞
  • Mendeley
  • 论文
  • RefWorks标记
  • Ref经理
  • RIS
  • Zotero
权限

做出评论

看到评论

下载
1878

分享

  • 文章
  • 图表和数据
  • 信息和披露
加载

文章图片及数据

数据

  • 表
  • Flowchart of Inclusion and Exclusion Criteria of Study Population in the CPRD CPRD = Clinical Practice Research Datalink; FRD = first registration date; TOD = transfer out date.
    " data-icon-position="" data-hide-link-title="0">图1
    • 下载图
    • 在新标签页打开
    • 下载演示文稿
    图1 珠江三角洲研究人群纳入及排除标准流程图

    临床实践研究数据链;FRD =首次注册日期;转出日期。

  • Cumulative Incidence Function Curves for Dementia Onset and for Death Using the Clinical Practice Research Datalink AD = Alzheimer disease.
    " data-icon-position="" data-hide-link-title="0">图2
    • 下载图
    • 在新标签页打开
    • 下载演示文稿
    图2 使用临床实践研究数据链的痴呆发病和死亡的累积发生率函数曲线

    阿尔茨海默病。

  • Bidirectional MR Analysis for the Associations Between Circulating Inflammatory Biomarker Levels and Diseases of Interest MR estimates were obtained from the Wald ratio method (NSNP = 1), from the inverse variance weighted (IVW) fixed-effects model (IVW-FE, NSNP = 2 or 3), or from the IVW random-effects model (IVW-RE, NSNP > 3). *p < 0.05 and **p < 0.05/533. AD = Alzheimer disease; Crohn = Crohn disease; IBD = inflammatory bowel disease; MR = Mendelian randomization; MS = multiple sclerosis; RA = rheumatoid arthritis; UC = ulcerative colitis.
    " data-icon-position="" data-hide-link-title="0">图3
    • 下载图
    • 在新标签页打开
    • 下载演示文稿
    图3 循环炎症生物标志物水平与相关疾病之间的双向MR分析

    MR估计值由Wald比值法(N单核苷酸多态性= 1),由逆方差加权(IVW)固定效应模型(IVW- fe, N单核苷酸多态性= 2或3),或从IVW随机效应模型(IVW- re, N单核苷酸多态性> 3). *p< 0.05和**p< 0.05/533。阿尔茨海默病;克罗恩病;IBD =炎症性肠病;孟德尔随机化;多发性硬化症;类风湿关节炎;溃疡性结肠炎。

  • Bidirectional MR Analysis for the Associations Between Circulating Inflammatory Biomarker Levels and Diseases of Interest (pWald < 0.05/533 or pIVW < 0.05/533) MR estimates were obtained from the Wald ratio method (NSNP = 1), from the inverse variance weighted (IVW) fixed-effects model (IVW-FE, NSNP = 2 or 3), or from the IVW random-effects model (IVW-RE, NSNP > 3). Red symbol indicates p < 0.05/695; larger blue symbol indicates 95% CI and does not include the null value. AD = Alzheimer disease; Crohn = Crohn disease; IBD = inflammatory bowel disease; IVW = inverse variance weighting; MR = Mendelian randomization; MS = multiple sclerosis; RA = rheumatoid arthritis; UC = ulcerative colitis; WM = weighted median.
    " data-icon-position="" data-hide-link-title="0">图4
    • 下载图
    • 在新标签页打开
    • 下载演示文稿
    图4 循环炎症生物标志物水平与相关疾病相关性的双向MR分析(p瓦尔德< 0.05/533或pIVW< 0.05/533)

    MR估计值由Wald比值法(N单核苷酸多态性= 1),由逆方差加权(IVW)固定效应模型(IVW- fe, N单核苷酸多态性= 2或3),或从IVW随机效应模型(IVW- re, N单核苷酸多态性> 3).红色符号表示p< 0.05/695;较大的蓝色符号表示95% CI,不包括空值。阿尔茨海默病;克罗恩病;IBD =炎症性肠病;IVW =逆方差加权;孟德尔随机化;多发性硬化症;类风湿关节炎;溃疡性结肠炎; WM = weighted median.

  • 表

    • 数据
    • 表1
    • 表2
    • 表格

    信件:快速在线通信

    本文尚未发表评论。
    评论

    需求

    如果你要上传关于文章的信件:
    您必须在六个月内更新您的披露:http://submit.半岛投注体育官网neurology.org

    您的合著者必须发送一份完整的出版协议表格来半岛投注体育官网(对于主要/通讯作者不需要填写以下表格即可),然后再上传您的评论。

    如果你在回复一篇关于你最初撰写的文章的评论:
    您(和共同作者)不需要填写表格或检查披露,因为作者表格仍然有效
    并适用于信件。

    提交规格:

    • 文章必须少于200字,参考文献少于5篇。参考文献1必须是你所评论的文章。
    • 投稿者不得超过5人。(例外:原作者回复可以包括文章的所有原作者)
    • 只可提交发稿日起6个月内发表的文章。
    • 不要冗余。在提交之前阅读文章上已经发布的任何评论。
    • 提交的意见在发表前须经过编辑和编辑审查。

    更多关于争议和辩论的指南和信息

    写评论

    更多关于文本格式的信息

    纯文本

    • 不允许使用HTML标记。
    • 网页地址和电子邮件地址会自动变成链接。
    • 行和段自动中断。
    作者信息
    注意:第一作者必须是注释的通讯作者。
    名字,名,名“彼得”。
    你的姓或姓。“MacMoody”。
    你的电子邮件地址,例如higgs-boson@gmail.com
    你的角色和/或职业。“整形外科医生”。
    所属机构或机构(如适用),例如"皇家自由医院"
    出版协议
    注意:除第一作者/通讯作者外,所有作者必须单独填写一份出版协议表格并在发表评论之前通过电子邮件提供给编辑部。
    验证码
    这个问题是为了测试你是否是一个人类访问者,并防止自动发送垃圾邮件。

    垂直制表符

    你可能也感兴趣

    回到顶部
    • 文章
      • 摘要
      • 术语表
      • 方法
      • 结果
      • 讨论
      • 研究资金
      • 信息披露
      • 鸣谢
      • 附录的作者
      • 脚注
      • 参考文献
    • 图表和数据
    • 信息和披露
    广告

    利妥昔单抗治疗青少年重症肌无力:法国的经验

    亨利·j·卡明斯基博士和莎拉·赖特博士

    ►看

    相关文章

    • 没有相关文章。

    主题讨论

    • 所有CBMRT/零假设
    • 所有的流行病学
    • 自身免疫性疾病
    • 阿尔茨海默病
    • 流行病学中的危险因素

    提醒我

    • 信件发表时通知我
    半岛投注体育官网神经学:100 (15)

    文章

    • 印刷前
    • 最新一期
    • 过去的问题
    • 受欢迎的文章
    • bdappcom

    关于

    • 关于期刊
    • 道德政策
    • 编辑和编委会
    • bdapp.
    • 做广告

    提交

    • 作者中心
    • 提交手稿
    • 审稿人信息
    • 河畔的指导方针
    • 权限

    用户

    • 订阅
    • 激活订阅
    • 注册eAlerts
    • RSS提要
    网站的标志
    • 访问Face半岛投注体育官网book上的neurology Template
    • 在Twitte半岛投注体育官网r上关注neurology Template
    • 在YouTu半岛投注体育官网be上访问神经病学
    • 半岛投注体育官网
    • 半岛投注体育官网神经学:临床实践
    • 半岛投注体育官网神经学:教育
    • 半岛投注体育官网神经学:遗传学
    • 半岛投注体育官网神经学:神经免疫学与神经炎症学
    • AAN.com
    • AANnews
    • 连续体
    • 大脑与生命
    • 半岛投注体育官网今天神经学

    威科集团标志

    半岛投注体育官网神经学|打印ISSN:0028-3878
    在线ISSN: 1526 - 632 x

    半岛综合体育官方app下载ios

    • 隐私政策
    • 反馈
    • 做广告
    Baidu
    map